These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9097752

  • 1. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK, Wishart PK, O'Donnell NP.
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [Abstract] [Full Text] [Related]

  • 2. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.
    Viswanathan AC, Fitzke FW, Hitchings RA.
    Br J Ophthalmol; 1997 Dec; 81(12):1037-42. PubMed ID: 9497460
    [Abstract] [Full Text] [Related]

  • 3. Is visual field evaluation using multiple correlations and linear regressions useful? An evaluation of Delphi perimetry.
    Wishart PK, Wardrop DR, Kosmin AS.
    Graefes Arch Clin Exp Ophthalmol; 1998 Jul; 236(7):493-500. PubMed ID: 9672794
    [Abstract] [Full Text] [Related]

  • 4. A comparison of five methods for estimating general glaucomatous visual field depression.
    Funkhouser A, Flammer J, Fankhauser F, Hirsbrunner HP.
    Graefes Arch Clin Exp Ophthalmol; 1992 Jul; 230(2):101-6. PubMed ID: 1577286
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA, Adams AJ, Casson EJ, Brandt JD.
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [Abstract] [Full Text] [Related]

  • 7. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry.
    Johnson CA, Adams AJ, Casson EJ, Brandt JD.
    Arch Ophthalmol; 1993 May; 111(5):651-6. PubMed ID: 8489448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.
    Tezel G, Dorr D, Kolker AE, Wax MB, Kass MA.
    Ophthalmology; 2000 Jun; 107(6):1194-9. PubMed ID: 10857843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diffuse visual field loss and glaucoma.
    Asman P, Heijl A.
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):303-8. PubMed ID: 7976259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice.
    Graham SL, Klistorner AI, Goldberg I.
    Arch Ophthalmol; 2005 Jun; 123(6):729-39. PubMed ID: 15955974
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.